Delivery Order SPE2DB20D2014-SPE2DB25FD16R
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,073.80 to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 mL auto-injector units on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, which is not subject to a set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $1,820.00 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of AJOVY 225 mg/1.5 ml auto-injector units. The contract, which carries no set-aside designation, represents a competitively awarded order with an ultimate completion date of September 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a $6,655.88 delivery order to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 mL auto-injector units, with a completion date of September 30, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is registered in the System for Award Management. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,597.47 to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 ml auto-injector units, with an ultimate completion date of September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency (DLA) awarded a $1,092.00 delivery order to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 mL auto-injector units, a pharmaceutical product used in the treatment of chronic migraine. This competitively awarded, firm fixed-price contract was issued on May 12, 2025, with an ultimate completion date of May 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside procurement, this order...
- The Defense Logistics Agency awarded a $4,554.55 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of AJOVY 225 mg/1.5 mL auto-injector units. The contract is classified as a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award utilized no set-aside provisions, reflecting the competitive nature of the procurement. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of AJOVY 225 mg/1.5 ml syringes, valued at $1,092.00, with a completion date of August 28, 2025. This non-competitive, firm fixed-price delivery order was issued on August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under the company's broader pharmaceutical supply relationship with the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of AJOVY 225 mg/1.5 mL auto-injector medication, valued at $1,300.58. This is a firm fixed-price delivery order with no set-aside designation, executed competitively under the company's larger indefinite delivery contract (IDC) vehicle with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of AJOVY (eptinezumab) 225 mg/1.5 mL auto-injector units valued at $1,187.64. This firm fixed-price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the Place of Performance located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,847.18 to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military treatment programs and facilities...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD16RDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,017.34 to AmerisourceBergen Drug Corp for the supply of AJOVY 225 mg/1.5 mL auto-injector units. This firm fixed-price delivery order, issued on September 29, 2025, represents a non-set-aside, competitively awarded contract with an ultimate completion date of September 30, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor, maintains an extensive portfolio of medical product deliveries across multiple therapeutic domains through the Defense Logistics Agency's Medical Supply Chain. The company's federal contract awards consistently demonstrate its capability to fulfill varied medical procurement requirements through open competition, with delivery orders involving firm fixed pricing that range from minimal transactions to substantial orders. The DLA is actively planning next-generation Pharmaceutical Prime Vendor Global Program contracts with the intent to make multiple regional awards, positioning AmerisourceBergen Drug Corp to continue serving military healthcare systems alongside the Defense Health Agency and other government healthcare organizations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 9/29/25 |